List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 23 studies with search of: "3-Iodobenzylguanidine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting A Study Evaluating Ultratrace Iobenguane I 131(MIBG)in Patients With Malignant Pheochromocytoma/Paraganglioma
Conditions: Pheochromocytoma;   Paraganglioma
Intervention: Radiation: Ultratrace Iobenguane I131
2 Recruiting Phase 1-2 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma
Conditions: Pheochromocytoma;   Paraganglioma
Intervention: Drug: Ultratrace Iobenguane (MIBG) I 131
3 Completed ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid
Conditions: Pheochromocytoma;   Paraganglioma;   Carcinoid
Intervention: Drug: Ultratrace iobenguane I 131
4 Recruiting 131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-Risk Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: 131I-MIBG , Etoposide, Melphalan, Carboplatin, Autologous Peripheral Stem Cell Transplantation
5 Active, not recruiting CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study
Condition: Neuroblastoma
Intervention: Drug: 131I-MIBG
6 Active, not recruiting 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Radiation: iodine I 131 metaiodobenzylguanidine
7 Recruiting Irinotecan, Vincristine, and Iodine I 131 Metaiodobenzylguanidine in Treating Young Patients With Resistant or Relapsed High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: irinotecan hydrochloride;   Drug: vincristine sulfate;   Radiation: iobenguane I 131
8 Recruiting Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Conditions: Neuroblastoma;   Pheochromocytoma
Intervention: Radiation: iobenguane I 131
9 Recruiting Iodine I 131 Metaiodobenzylguanidine and a Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Procedure: autologous bone marrow transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: quality-of-life assessment;   Procedure: radionuclide imaging;   Radiation: cold contaminant-free iodine I 131 metaiodobenzylguanidine
10 Recruiting Iodine I 131 Metaiodobenzylguanidine, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell or Bone Marrow Transplant for Relapsed or Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: etoposide;   Drug: melphalan;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: iobenguane I 131;   Radiation: radiation therapy
11 Suspended High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors
Conditions: Neuroendocrine Tumors;   Metastases, Neoplasm
Intervention: Drug: I-131 Metaiodobenzylguanidine
12 Active, not recruiting Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation in Treating Patients With Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: iodine I 131 metaiodobenzylguanidine
13 Withdrawn High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: iodine I 131 metaiodobenzylguanidine;   Drug: topotecan hydrochloride;   Procedure: chemotherapy;   Procedure: peripheral blood stem cell transplantation;   Procedure: radioisotope therapy;   Procedure: radionuclide imaging;   Procedure: radiosensitization;   Procedure: total-body irradiation
14 Completed Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma
Conditions: Pheochromocytoma;   Neuroblastoma
Intervention: Drug: 123I-mIBG (meta-iodobenzylguanidine)
15 Active, not recruiting Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease
Condition: Heart Failure, Congestive
Intervention: Drug: 123I-mIBG (meta-iodobenzylguanidine)
16 Active, not recruiting Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease
Condition: Heart Failure, Congestive
Intervention: Drug: 123I-mIBG (meta-iodobenzylguanidine)
17 Active, not recruiting Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: etoposide;   Drug: melphalan;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: iodine I 131 metaiodobenzylguanidine;   Radiation: radiation therapy
18 Recruiting Haploidentical Stem Cell Transplantation in Neuroblastoma
Conditions: Neuroblastoma;   Hematopoietic Stem Cell Transplantation;   Radiotherapy;   Immunotherapy
Interventions: Drug: iodine I 131 metaiodobenzylguanidine;   Drug: Fludarabine;   Drug: Thiotepa;   Procedure: T-cell depletion;   Procedure: Haploidentical stem cell transplantation;   Procedure: Donor Lymphocyte Infusion;   Drug: Rituximab;   Procedure: Co-transplantation of mesenchymal stem cells
19 Recruiting Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: ifosfamide;   Drug: isotretinoin;   Drug: melphalan;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous hematopoietic stem cell transplantation;   Radiation: iobenguane I 131;   Radiation: radiation therapy
20 Recruiting Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: ifosfamide;   Drug: isotretinoin;   Drug: melphalan;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: iobenguane I 131;   Radiation: radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-23)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services